Efficacy of rituximab in gastric diffuse large B cell lymphoma patients.

Abstract

AIM To evaluate retrospectively the efficacy of rituximab plus chemotherapy in gastric diffuse large B cell lymphoma (DLBCL). METHODS Sixty patients (median age: 58 years) with histologically confirmed gastric DLBCL treated at four Italian institutions between 2000 and 2007, were included in this analysis. Patients were selected by stage (I-IV, Lugano… (More)

Topics

  • Presentations referencing similar topics